Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    Role of salpingectomy at the time of urogynecologic surgery.

    Curr Opin Obstet Gynecol 2015 Oct;27(5):385-9
    Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
    Purpose Of Review: This article reviews the current literature about prophylactic bilateral salpingectomy and provides guidelines for clinicians in regard to the inclusion of salpingectomy at the time of urogynecologic surgery.

    Recent Findings: After the Nurses' Health Study showed that all-cause mortality was increased in women undergoing oophorectomy at the time of hysterectomy for benign indications, there was a shift in focus toward ovarian conservation at the time of gynecologic surgery. As there has been continued interest in the fallopian tube as the origin of ovarian cancer, a move toward prophylactic salpingectomy has occurred. This strategy has become widely accepted in high-risk women, but is not universal in either premenopausal or postmenopausal women who are primarily served by the urogynecologic community.

    Summary: Current literature supports that, if easily accessible, the fallopian tubes should be removed at the time of urogynecologic surgery. In premenopausal women, salpingectomy does not likely affect ovarian reserve, but this possibility should be discussed with patients. If inaccessible (i.e., at the time of a midurethral sling), there should not be additional surgery performed to access the fallopian tubes. In addition, the pathologic evaluation of the fallopian tubes should include complete examination of the fimbriae and a representative section of the nonfimbriated portion.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with
    Source Status ListingPossible

    Similar Publications

    Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
    Surg Oncol 2015 Dec 8;24(4):335-44. Epub 2015 Oct 8.
    Division of Gynaecologic Oncology, 12 de Octubre University Hospital, Madrid, Spain.
    At present, there is no effective screening of ovarian cancer. Primary prevention may be the only strategy to decrease the mortality from ovarian cancer, not only in women at high risk but also at low risk. Several recent studies have identified the distal fimbriae end of the fallopian tubes as primary precursor of High-grade serous carcinoma. Read More
    Role of Fallopian Tubes in the Development of Ovarian Cancer.
    J Minim Invasive Gynecol 2017 02 19;24(2):230-234. Epub 2016 Dec 19.
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
    Ovarian cancer is the leading cause of death from gynecologic malignancy and the fifth cause of cancer death in women in the United States. The most common and lethal histologic subtype of epithelial ovarian cancer is high-grade serous carcinoma (HGSC), which generally presents at an advanced stage. HGSC may be associated with BRCA1 and BRCA2 mutations. Read More
    Salpingectomy as a means to reduce ovarian cancer risk.
    Cancer Prev Res (Phila) 2015 May 13;8(5):342-8. Epub 2015 Jan 13.
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
    Bilateral salpingo-oophorectomy (BSO) has become the standard-of-care for risk reduction in women at hereditary risk of ovarian cancer. Although this procedure significantly decreases both the incidence of and mortality from ovarian cancer, it affects quality of life, and the premature cessation of ovarian function may have long-term health hazards. Recent advances in our understanding of the molecular pathways of ovarian cancer point to the fallopian tube epithelium as the origin of most high-grade serous cancers (HGSC). Read More
    Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Aust N Z J Obstet Gynaecol 2015 Dec 7;55(6):606-11. Epub 2015 Sep 7.
    University of Sydney, Sydney, New South Wales, Australia.
    Background: Recent evidence supports the fallopian tube as the site of origin for many pelvic serous cancers (PSC) including epithelial ovarian cancers (EOC). As a result, a change in practice with opportunistic bilateral salpingectomy (OBS) at the time of hysterectomy has been advocated as a preventative strategy for PSC in a low-risk population.

    Aims: The aim of this study was to assess current clinical practice in Australia with respect to OBS during gynaecological surgery for benign indications. Read More